Reinhard Büttner

29.2k total citations · 2 hit papers
354 papers, 11.4k citations indexed

About

Reinhard Büttner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Reinhard Büttner has authored 354 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Oncology, 125 papers in Pulmonary and Respiratory Medicine and 97 papers in Molecular Biology. Recurrent topics in Reinhard Büttner's work include Lung Cancer Treatments and Mutations (58 papers), Cancer Genomics and Diagnostics (53 papers) and Genetic factors in colorectal cancer (34 papers). Reinhard Büttner is often cited by papers focused on Lung Cancer Treatments and Mutations (58 papers), Cancer Genomics and Diagnostics (53 papers) and Genetic factors in colorectal cancer (34 papers). Reinhard Büttner collaborates with scholars based in Germany, United States and Switzerland. Reinhard Büttner's co-authors include Sabine Merkelbach‐Bruse, Anja‐Katrin Bosserhoff, Eva Wardelmann, H. Kurz, M. Nagel, P. Haring Bolívar, M. Brucherseifer, Josef Rüschoff, Hans‐Ulrich Schildhaus and Di Shi and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Reinhard Büttner

328 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

2008 904 citations Reinhard Büttner et al. profile →
Implementing TMB measurement in clinical practice: considerations on assay requirements

2019 247 citations Reinhard Büttner, Sabine Merkelbach‐Bruse et al. profile →

Peers

Countries citing papers authored by Reinhard Büttner

Since Specialization

Citations

This map shows the geographic impact of Reinhard Büttner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reinhard Büttner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reinhard Büttner more than expected).

Fields of papers citing papers by Reinhard Büttner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reinhard Büttner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reinhard Büttner. The network helps show where Reinhard Büttner may publish in the future.

Co-authorship network of co-authors of Reinhard Büttner

This figure shows the co-authorship network connecting the top 25 collaborators of Reinhard Büttner. A scholar is included among the top collaborators of Reinhard Büttner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reinhard Büttner. Reinhard Büttner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multimodal Approach Predicts Relapse upon Cessation of Immune Checkpoint Inhibitors in Advanced Melanoma 2025 ·Clinical Cancer Research ·Ka‐Won Noh, (unknown), Doris Helbig, (unknown), (unknown), Max Schlaak, Tilo Biedermann, Reinhard Büttner, (unknown)	0
2	Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score 2024 ·npj Precision Oncology ·(unknown), Andreas H. Scheel, Margaret Dugan, Robert Wild, (unknown), Barbara Holz, Johannes Brägelmann, Svenja Wagener‐Ryczek, Sabine Merkelbach‐Bruse, Juergen Wolf, Reinhard Büttner, (unknown), Matthias Scheffler, Axel M. Hillmer	0
3	BIOLUMA: A phase II trial of nivolumab and ipilimumab in lung cancer—Results from the SCLC TMB^high cohort. 2024 ·Journal of Clinical Oncology ·Rieke Fischer, Julie George, (unknown), Hans Anton Schloesser, (unknown), Peter Brossart, Walburga Engel-Riedel, Frank Griesinger, Christian Grohé, (unknown), Kathrin Nachtkamp, Jens Panse, Martin Sebastian, Rainer Wiewrodt, Reinhard Büttner, Roman K. Thomas, Juergen Wolf	1
4	Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion–Positive Pancreatic Adenocarcinoma: A Case Report 2023 ·JCO Precision Oncology ·(unknown), Jana Fassunke, Michael Püsken, (unknown), Elke Binot, Anna Eisert, Rieke Fischer, Lucia Nogová, Richard Riedel, (unknown), (unknown), Matthias Scheffler, H. Schulz, (unknown), Thomas Zander, Sabine Merkelbach‐Bruse, Peter Schirmacher, Reinhard Büttner, Jürgen Wolf, Sebastian Michels	2
5	The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer 2021 ·Oncogene ·Seng Chuan Tang, (unknown), Olivier Peulen, (unknown), (unknown), Alice Mayer, (unknown), Pierre Close, Sebastian Klein, Alexandra Florin, Reinhard Büttner, Ivan Nemazanyy, Kateryna Shostak, Alain Chariot	10
6	Mutations in circulating cell‐free tumour DNA: Predictors of survival in hepatocellular carcinoma 2021 ·Minerva Access (University of Melbourne) ·Jessica Howell, Stephen R. Atkinson, David J. Pinato, Shahid A. Khan, Rosalba Minisini, Michela Emma Burlone, Monica Leutner, Mario Pirisi, Reinhard Büttner, Margarete Odenthal, Rohini Sharma	1
7	LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma—Potential Biomarkers for Targeted Therapy Concepts 2020 ·International Journal of Molecular Sciences ·Nora Wuerdemann, (unknown), (unknown), (unknown), Claus Wittekindt, Christian U. Huebbers, Shachi Jenny Sharma, (unknown), Stefan Gattenlöhner, Reinhard Büttner, Ernst‐Jan M. Speel, (unknown), Steffen Wagner, Alexander Quaas, Jens Peter Klußmann	36
8	Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury 2020 ·Cells ·(unknown), Christoph Dorn, Erwin Gäbele, Frauke Bataille, K Freese, Tatjana Seitz, Wolfgang E. Thasler, Reinhard Büttner, Ralf Weiskirchen, Anja‐Katrin Bosserhoff, Claus Hellerbrand	8
9	HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma 2019 ·BMC Cancer ·Patrick Sven Plum, Florian Gebauer, Maxwell Kramer, Hakan Alakus, Felix Berlth, Seung‐Hun Chon, Lars M. Schiffmann, Thomas Zander, Reinhard Büttner, Arnulf H. Hölscher, Christiane J. Bruns, Alexander Quaas, Heike Loeser	57
10	The Endosomal Protein CEMIP Links WNT Signaling to MEK1–ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids 2018 ·Cancer Research ·(unknown), Ivan Nemazanyy, Florian Rambow, Seng Chuan Tang, Sylvain Delaunay, Lars Tharun, Alexandra Florin, Reinhard Büttner, (unknown), Pierre Close, Jean‐Christophe Marine, Kateryna Shostak, Alain Chariot	37
11	Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment 2018 ·PLoS ONE ·Michaela A. Ihle, Sebastian Huss, (unknown), Wolfgang Hartmann, Sabine Merkelbach‐Bruse, Hans‐Ulrich Schildhaus, Reinhard Büttner, Harri Sihto, Kirsten Sundby Hall, Mikael Eriksson, Peter Reichardt, Heikki Joensuu, Eva Wardelmann	18
12	ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma 2017 ·Cancer Research ·Anna Schmitt, Gero Knittel, (unknown), Tsun-Po Yang, Julie George, Michael A. Nowak, Uschi Leeser, Reinhard Büttner, Sven Perner, Martin Peifer, Hans Christian Reinhardt	82
13	Mechanisms of Primary Drug Resistance in FGFR1 -Amplified Lung Cancer 2017 ·Clinical Cancer Research ·Florian Malchers, Meryem S. Ercanoglu, (unknown), Roberta Castiglione, Verena Tischler, Sebastian Michels, Ilona Dahmen, Johannes Brägelmann, Roopika Menon, Johannes M. Heuckmann, Julie George, Sascha Ansén, Martin L. Sos, Alex Soltermann, Martin Peifer, Jürgen Wolf, Reinhard Büttner, Roman K. Thomas	41
14	The Prosurvival IKK-Related Kinase IKKϵ Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine 2016 ·Cancer Research ·Serkan İsmail Göktuna, Kateryna Shostak, Tieu‐Lan Chau, Lukas C. Heukamp, Benoît Hennuy, Hong‐Quan Duong, Aurélie Ladang, Pierre Close, Iva Klevernic, (unknown), Alexandra Florin, Grégory Ehx, Frédéric Baron, (unknown), Souad Rahmouni, Lars Vereecke, Geert Loo, Reinhard Büttner, Florian R. Greten, Alain Chariot	19
15	Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer 2016 ·Clinical Cancer Research ·Julie George, Motonobu Saito, Koji Tsuta, Reika Iwakawa, Kouya Shiraishi, Andreas H. Scheel, (unknown), Shun‐ichi Watanabe, Ryo Nishikawa, Masayuki Noguchi, Martin Peifer, Se Jin Jang, Iver Petersen, Reinhard Büttner, Curtis C. Harris, Jun Yokota, Roman K. Thomas, Takashi Kohno	93
16	STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs 2016 ·Cancer Research ·Barbara Walch‐Rückheim, (unknown), (unknown), Claudia Wickenhauser, Lars Christian Horn, Lars Tharun, Reinhard Büttner, Peter Mallmann, Peter L. Stern, Yoo-Jin Kim, Rainer M. Bohle, Christian Rübe, (unknown), Ingolf Juhasz‐Böss, Erich‐Franz Solomayer, Sigrun Smola	43
17	Reprogramming of the ERRα and ERα Target Gene Landscape Triggers Tamoxifen Resistance in Breast Cancer 2015 ·Cancer Research ·Verena Thewes, Ronald Simon, (unknown), Magdalena Schlotter, Tobias Anzeneder, Reinhard Büttner, Vladimı́r Beneš, Guido Sauter, Barbara Burwinkel, Robert I. Nicholson, Hans‐Peter Sinn, Andreas Schneeweiß, Ulrich Deuschle, Marc Zapatka, Stefanie Heck, Peter Lichter	35
18	Mast cells play a protumorigenic role in primary cutaneous lymphoma 2012 ·Blood ·Anja Rabenhorst, Max Schlaak, Lukas C. Heukamp, Anja Förster, Sebastian Theurich, Michael von Bergwelt‐Baildon, Reinhard Büttner, Peter Kurschat, Cornelia Mauch, Axel Roers, Karin Hartmann	105
19	Uncommon Presentation of a Uterine Lipoleiomyoma 2011 ·Journal of Gynecologic Surgery ·Oliver Gembruch, (unknown), Reinhard Büttner	1
20	Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down-modulation # 2008 ·Hepatology ·(unknown), Thomas Schmidt, Christian Kurts, Qi Zhou, Dawid Eckert, Dean W. Felsher, Hubert Schorle, Percy A. Knolle, Thomas Tüting, Winfried Barchet, Reinhard Büttner, Andreas Limmer, Ines Gütgemann	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact